|
|
|
| home > white papers > Changing Structural Landscape for Comparator Drug Supply - ADAllen Pharma |
|
|
 WHITE PAPERS |
|
ADAllen Pharma
|
|
Changing Structural Landscape for Comparator Drug Supply
|
|
TransCelerate BioPharma is focused on advancing innovation in R&D,
identifying and solving common R&D challenges and further improving
patient safety, with the goal of delivering more high quality medicines
to patients. In 2013, they announced its Clinical Trial Comparator
Network initiative to show a mutual commitment to offer secure and rapid
supply of comparator drug products. The aim of this article is to
unpack the section on 'Comparator Drugs' and analyse the rationale for
attempting to achieve their objectives.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
A new market reference added to Safe’n’Sound®, our passive safety device platform
Safe’n’Sound® is on the market in Europe with a newly registered injectable medication.
The commercial launch of HULIO™ (Adalimumab Biosimilar) was initiated in selected European markets on October 19,2018.
Hulio™, developed by Fujifilm Kyowa Kirin Biologics Co., Ltd. and marketed in the European Union by Mylan N.V. is approved as a biosimilar for the same indications as the reference product, Humira®.
More info >> |
|
 |
White Papers |
 |
|
 |
Industry Events |
 |
ESMO Targeted Anticancer Therapies Congress 2020
2-4 March 2020, Paris, France
A unique and international mix of experts, researchers and decision
makers both from academia and industry across the globe, will convene
in Paris for a three-day Congress aiming at exchanging knowledge,
experience and research innovations in cancer.
TAT
2020 will focus, among others, on novel strategies in immuno-oncology,
personalised medicine and molecular tumour boards, preclinical studies
to identify effective combination therapies, use of microbiome, tumour
agnostic trials, ADC technology, oncolytics, multispecific biological
constructs and targeting cytokines.
Participating in TAT 2020 will offer you the possibility to take part in
interdisciplinary discussions inspiring new ideas and new
collaborations.
More info >> |
|
|
|
